Planet 13 Holdings (PLNH) Total Non-Current Liabilities (2020 - 2026)
Planet 13 Holdings (PLNH) reported Total Non-Current Liabilities of $66.1 million for Q1 2026, down 27.98% year-over-year from $91.8 million in Q1 2025, and down 2.9% quarter-over-quarter from $68.1 million in Q4 2025.
Planet 13 Holdings (PLNH) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 7 years of Total Non-Current Liabilities data on file, last reported at $66.1 million in Q1 2026.
- Total Non-Current Liabilities for Q1 2026 came in at $66.1 million, down 27.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $66.1 million (down 27.98% YoY), and the FY2025 annual result was $68.1 million, down 8.82% from the prior year.
- Total Non-Current Liabilities eased to $66.1 million in Q1 2026 per PLNH's latest filing, from $68.1 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $92.3 million in Q3 2024 and troughed at $35.5 million in Q2 2022.
- A 5-year average of $58.6 million and a median of $45.6 million in 2024 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2022 and 2026: Total Non-Current Liabilities surged 123.78% in 2022, then dropped 27.98% in 2026.
- A 5-year view of Total Non-Current Liabilities shows it stood at $42.7 million in 2022, then advanced by 3.19% to $44.1 million in 2023, then soared by 69.36% to $74.7 million in 2024, then decreased by 8.82% to $68.1 million in 2025, then dropped by 2.9% to $66.1 million in 2026.
- Business Quant data shows PLNH's Total Non-Current Liabilities at $66.1 million in Q1 2026, $68.1 million in Q4 2025, and $74.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 18.28 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 11.64 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 44.12 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.24 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.26 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.44 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.81 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.13 Bn |
| 10 | Planet 13 Holdings | - | - | 9.41 Mn | 66.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66.14 Mn |
| Dec 31, 2025 | 68.11 Mn |
| Sep 30, 2025 | 73.96 Mn |
| Jun 30, 2025 | 76.15 Mn |
| Mar 31, 2025 | 91.83 Mn |
| Dec 31, 2024 | 74.70 Mn |
| Sep 30, 2024 | 92.25 Mn |
| Jun 30, 2024 | 84.34 Mn |
| Mar 31, 2024 | 45.62 Mn |
| Dec 31, 2023 | 44.11 Mn |
| Sep 30, 2023 | 41.49 Mn |
| Jun 30, 2023 | 40.47 Mn |
| Mar 31, 2023 | 40.97 Mn |
| Dec 31, 2022 | 42.74 Mn |
| Sep 30, 2022 | 35.88 Mn |
| Jun 30, 2022 | 35.50 Mn |
| Mar 31, 2022 | 41.17 Mn |
| Dec 31, 2021 | 35.90 Mn |
| Mar 31, 2021 | -173.11 Mn |
| Dec 31, 2020 | -119.91 Mn |